Dr. Vaibhav Agrawal

Claim this profile

City of Hope Medical Center

Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Myeloid Leukemia
2 reported clinical trials
4 drugs studied

Area of expertise

1T-Lymphoblastic Leukemia/Lymphoma
Vaibhav Agrawal has run 2 trials for T-Lymphoblastic Leukemia/Lymphoma. Some of their research focus areas include:
HLA-A positive
HLA-A negative
HLA positive
2Myeloid Leukemia
Vaibhav Agrawal has run 2 trials for Myeloid Leukemia. Some of their research focus areas include:
HLA-A positive
HLA-A negative
HLA positive

Affiliated Hospitals

Image of trial facility.
City Of Hope Medical Center

Clinical Trials Vaibhav Agrawal is currently running

Image of trial facility.

CMV-MVA Triplex Vaccine

for Blood Cancers

This phase II clinical trial tests how well the cytomegalovirus-modified vaccinica Ankara (CMV-MVA) Triplex vaccine given to human leukocyte antigens (HLA) matched related stem cell donors works to prevent cytomegalovirus (CMV) infection in patients undergoing hematopoietic stem cell transplant. The CMV-MVA Triplex vaccine works by causing an immune response in the donors body to the CMV virus, creating immunity to it. The donor then passes that immunity on to the patient upon receiving the stem cell transplant. Giving the CMV-MVA triplex vaccine to donors may help prevent CMV infection of patients undergoing stem cell transplantation.
Recruiting0 awards Phase 223 criteria
Image of trial facility.

Pembrolizumab + Decitabine with or without Venetoclax

for Acute Myeloid Leukemia or Myelodysplastic Syndrome

This phase Ib trial studies the side effects and best dose of pembrolizumab and how well it works in combination with decitabine with or without venetoclax in treating patients with acute myeloid leukemia or myelodysplastic syndrome that is newly-diagnosed, has come back (recurrent), or does not respond to treatment (refractory). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Decitabine is in a class of medications called hypomethylation agents. It works by helping the bone marrow produce normal blood cells and by killing abnormal cells in the bone marrow. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. This trial may help doctors find the best dose of pembrolizumab that can be safely given in combination with decitabine with or without venetoclax, and to determine what side effects are seen with this treatment.
Recruiting3 awards Phase 11 criteria

More about Vaibhav Agrawal

Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Vaibhav Agrawal has experience with
  • CMV-MVA Triplex Vaccine
  • Decitabine
  • Pembrolizumab
  • Venetoclax

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vaibhav Agrawal specialize in?
Vaibhav Agrawal focuses on T-Lymphoblastic Leukemia/Lymphoma and Myeloid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Vaibhav Agrawal currently recruiting for clinical trials?
Yes, Vaibhav Agrawal is currently recruiting for 2 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Vaibhav Agrawal has studied deeply?
Yes, Vaibhav Agrawal has studied treatments such as CMV-MVA Triplex Vaccine, Decitabine, Pembrolizumab.
What is the best way to schedule an appointment with Vaibhav Agrawal?
Apply for one of the trials that Vaibhav Agrawal is conducting.
What is the office address of Vaibhav Agrawal?
The office of Vaibhav Agrawal is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.